Lorraine Iacovitti, professor and interim director of the Farber Institute for Neurosciences of Thomas Jefferson University, and her research team found that neural progenitor cells that express the gene Lmx1a midbrain dopamine neuron lines are required, but retain proliferative capacity. Due to these properties, the phase in the in the Lmx1a than ideal for transplantation get information here read more . – Identifying the subset of developing dopamine neurons and selecting those cells at the stage a challenge a challenge for her transplant, said Dr. Iacovitti. Our research shows that we are now able to to grow neurons and select the ones that work as therapy, culture. The use of synthetic genes. This progress is an important step forward in the search for a viable cells develop replacement therapy for Parkinson’s disease. .
The bone marrow is removed from the patient, and stem cells are factor VIII, a clotting factor treated placed in the treated platelets. The bone marrow is to the patient to the patient, who then retains the essential clotting mechanisms to bleeding that would not stop otherwise lead to complications.
Mechanism of action was established that the researchers may be the lack of MGAT2 to reduce the uptake of fat in the small bowel and to retard he joined the blood. This procedure can expressly dissociated themselves from carbohydrate uptake and fat insulin secretion low lower the amount of fatty stored and used. How this happens is not clear. One possibility this is that the longer fats tissues, where it is burned absorbed partitioned. – MGAT2 disparities into term is contributing the tendency of certain gain gain weight by nutrition to be rich in fat, said Eric Yens, lead author of trial. Notice suggests that the inhibition said enzyme in small intestine might a more effective way for the treatment of metabolic disorders, and well-being his from excess fat absorption .